Valuation & Market

With a NASDAQ bell ringing set, SuRo Capital's upcoming earnings will test if its big bets on private AI firms have paid off for public investors.

With a 10-K filed and new acquisitions, THC Therapeutics is fighting to shed its obscure market status and build a vertically integrated cannabis powerhouse.

A novel drug delivery system could revolutionize Alzheimer's treatment, and Acumen Pharmaceuticals is leading the charge with its targeted therapy.

As Uni-Fuels blankets Thailand with bunkering services, the move highlights the nation's rising maritime importance and the intense battle for market share.

The digital asset giant is delisting from Toronto to streamline costs, a move that reshapes its buyback plan and how Canadian investors trade its stock.

EcoVadis awards highlight a major shift: sustainability is no longer about compliance, but a core driver of performance, resilience, and long-term value.

As hearing loss surges globally, Amplifon launches a worldwide campaign of free tests and awareness, blending public health with strategic market leadership.

As Sri Lanka emerges from its economic crisis, a first-of-its-kind European-regulated fund provides a liquid, secure path to its undervalued assets.

Antelope Enterprise Holdings just bought $1M in Bitcoin, launching its 'Genius Plan.' But with falling revenue, is this a bold new chapter or a risky bet?

Endeavour Silver saw record 2025 revenue from new mines but posted a $119M loss due to financial instruments, high costs, and rising security risks in Mexico.

After a challenging year, InTest Corp. posts a strong Q4 rebound, driven by growth in non-semi markets. A robust backlog signals a promising 2026.

Sysco's latest dividend declaration offers more than shareholder returns; it provides a key signal on the health of the global food service industry.

The AI semiconductor firm posts 37% annual revenue growth and a return to non-GAAP profit, proving its strategic pivot to intelligent edge devices is a success.

Viridien posts impressive 2025 profit growth and debt reduction, announcing a new CEO to navigate a selective, tech-focused deepwater exploration boom.

After a strong 2025, Viatris unveils a plan for $650M in savings, a 10% workforce cut, and a focus on six new drugs to fuel future innovation.

The therapy giant reports robust revenue growth and record patient visits, backed by major acquisitions and new 10-year hospital system alliances.

Engineering giant Stantec reports a landmark year with $6.5B revenue, hitting strategic targets early, and raises its dividend, signaling strong future growth.

With a record $411M backlog and surging revenue, Redwire's strategic pivot to defense and space comes at a high cost. Can it turn growth into profit?

MiMedx reports record 2025 sales and a $100M buyback, but faces a major challenge from new Medicare reimbursement rules set to disrupt the wound care market.

Global home care provider Dovida acquires U.S. franchise A Place At Home, bringing its international, person-centered model to an aging America.